Albert Wong

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. pmc Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
    Chan Juan Shen
    Translational Research Center, Zhengzhou University People s Hospital, 7 Weiwu Road, Zhengzhou, Henan 450003, China
    J Hematol Oncol 6:33. 2013
  2. pmc Development of an EGFRvIII specific recombinant antibody
    Puja Gupta
    Brain Tumor Research Laboratories, Department of Neurosurgery, and Program in Cancer Biology, Stanford University Medical Center, Stanford, CA 94305, USA
    BMC Biotechnol 10:72. 2010
  3. ncbi request reprint Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme
    Catherine A Del Vecchio
    Stanford University, 300 Pasteur Drive, Edwards R213, Stanford, CA 94305, USA
    Curr Opin Mol Ther 12:741-54. 2010

Collaborators

  • Puja Gupta
  • Chan Juan Shen
  • Shuang Yin Han
  • Catherine A Del Vecchio
  • Ethan Q Han
  • Ying Ying Zhao
  • Yu xiu Yang
  • Yun Fei Wang
  • Na Cao
  • Jian Cui
  • Yi Wang
  • Li ming Zhao
  • Gordon Li
  • Siddhartha S Mitra
  • Marina Holgado-Madruga
  • Ryan T Nitta

Detail Information

Publications3

  1. pmc Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
    Chan Juan Shen
    Translational Research Center, Zhengzhou University People s Hospital, 7 Weiwu Road, Zhengzhou, Henan 450003, China
    J Hematol Oncol 6:33. 2013
    ..Our current study aimed to investigate the specific and efficient antitumor effect of T cells modified with CAR containing inducible costimulator (ICOS) signaling domain...
  2. pmc Development of an EGFRvIII specific recombinant antibody
    Puja Gupta
    Brain Tumor Research Laboratories, Department of Neurosurgery, and Program in Cancer Biology, Stanford University Medical Center, Stanford, CA 94305, USA
    BMC Biotechnol 10:72. 2010
    ..Furthermore, a monoclonal antibody to EGFRvIII is not readily available to the scientific community...
  3. ncbi request reprint Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme
    Catherine A Del Vecchio
    Stanford University, 300 Pasteur Drive, Edwards R213, Stanford, CA 94305, USA
    Curr Opin Mol Ther 12:741-54. 2010
    ..Phase I and II clinical trials in patients with GBM were ongoing at the time of publication. In the future, it may be beneficial to combine rindopepimut with other treatment modalities to further prolong survival...

Research Grants31

  1. NOVEL EFFECTORS OF GRB2 IN HUMAN GLIAL TUMORS
    Albert Wong; Fiscal Year: 2003
    ..abstract_text> ..
  2. Using Insights from EGFRvIII to Improve EGFR Directed Therapy in Human Gliomas
    Albert Wong; Fiscal Year: 2007
    ..This work will reveal new insights into the properties of EGFR and EGFRvlll and will yield information that can be applied to the creation of new drugs and therapies for glioblastoma tumors. ..
  3. The Role of JNK in Glial Tumor Pathogenesis
    Albert Wong; Fiscal Year: 2006
    ..This work will further enhance our knowledge of this novel signaling pathway in this human cancer and provide new avenues for diagnostics and therapeutics. ..
  4. NOVEL EFFECTORS OF GRB2 IN HUMAN GLIAL TUMORS
    Albert Wong; Fiscal Year: 2009
    ..abstract_text> ..
  5. ALTERED EGF RECEPTORS IN HUMAN GLIOMAS
    Albert Wong; Fiscal Year: 1993
    ..These studies will add to our understanding of these tumors. A clinically useful application resulting from this research will be to use the information about the abnormal sequences to derive tumor specific monoclonal antibodies...
  6. ALTERED EGF RECEPTORS IN HUMAN GLIAL TUMORS
    Albert Wong; Fiscal Year: 2001
    ..The structure of alternative transcripts from the Gab1 gene in tumors will be determined and their effects on transformation and signaling will be evaluated. ..
  7. Using Insights from EGFRvIII to Improve EGFR Directed Therapy in Human Gliomas
    Albert J Wong; Fiscal Year: 2010
    ..This work will reveal new insights into the properties of EGFR and EGFRvlll and will yield information that can be applied to the creation of new drugs and therapies for glioblastoma tumors. ..